Sonia Denise Bell, MD
Sports Medicine · San Francisco
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 9
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bell’s office at (415) 363-0466 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A85402 · Current
Licensed to practise in California · since 2003 · expires 2027-09-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$4,156
Pharmacies billed $4,156 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 38% of their Part D prescriptions (75 of 198) in 2024. A higher opioid share than 9 in 10 peers; the typical physical medicine & rehabilitation clinician is at 0%. Long-acting opioids: 15% of their opioid prescriptions.
197 generic and fewer than 11 brand-name prescriptions · $4,156 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone-Acetaminophen | 20 | $2,235 | $112 |
| Oxycodone | 12 | $260 | $22 |
| Gabapentin | 32 | $252 | $8 |
| Ibuprofen | 23 | $222 | $10 |
| Hydrocodone-Acetaminophen | 25 | $190 | $8 |
See all 7 drugs
| Oxycodone-Acetaminophen | 20 | $2,235 | $112 |
| Oxycodone | 12 | $260 | $22 |
| Gabapentin | 32 | $252 | $8 |
| Ibuprofen | 23 | $222 | $10 |
| Hydrocodone-Acetaminophen | 25 | $190 | $8 |
| Morphine Sulfate Er | 11 | $61 | $6 |
| Cyclobenzaprine | 12 | $55 | $5 |
Year by year
| 2024 | 198 | 11 | 38% (75) | None | $4,156 |
| 2023 | 222 | None | 28% (62) | 0% | $3,712 |
| 2022 | 186 | None | 36% (67) | None | $5,816 |
| 2021 | 154 | 11 | 43% (66) | None | $5,412 |
| 2020 | 159 | 12 | 39% (62) | None | $3,486 |
| 2019 | 159 | 13 | 39% (62) | None | $11,860 |
| 2018 | 113 | None | 45% (51) | None | $4,482 |
| 2017 | 98 | None | 53% (52) | 0% | $3,327 |
| 2016 | 112 | 14 | 48% (54) | None | $7,502 |
| 2015 | 114 | 18 | 62% (71) | 19% | $8,965 |
| 2014 | 14 | None | None | 0% | $200 |
| 2013 | 17 | None | None | 0% | $1,597 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Hydrocodone-Acetaminophen | 24 | $692 | $29 |
| Oxycodone-Acetaminophen | 22 | $394 | $18 |
| Gabapentin | 31 | $375 | $12 |
| Ibuprofen | 31 | $313 | $10 |
| Methocarbamol | 11 | $192 | $17 |
| Duloxetine | 11 | $181 | $16 |
| Omeprazole | 13 | $59 | $5 |
| Tizanidine | 16 | $51 | $3 |
| Promethazine | 11 | $16 | $1 |
2022: 8 drugs
| Oxycodone | 11 | $1,082 | $98 |
| Hydrocodone-Acetaminophen | 25 | $654 | $26 |
| Nabumetone | 13 | $548 | $42 |
| Oxycodone-Acetaminophen | 22 | $401 | $18 |
| Cyclobenzaprine | 17 | $196 | $12 |
| Ibuprofen | 17 | $183 | $11 |
| Gabapentin | 12 | $127 | $11 |
| Omeprazole | 14 | $104 | $7 |
2021: 7 drugs
| Oxycodone-Acetaminophen | 18 | $601 | $33 |
| Hydrocodone-Acetaminophen | 18 | $269 | $15 |
| Morphine Sulfate Er | 12 | $190 | $16 |
| Omeprazole | 16 | $157 | $10 |
| Gabapentin | 12 | $111 | $9 |
| Ibuprofen | 11 | $91 | $8 |
| Methocarbamol | 12 | $86 | $7 |
2020: 6 drugs
| Oxycodone-Acetaminophen | 19 | $404 | $21 |
| Morphine Sulfate Er | 13 | $282 | $22 |
| Hydrocodone-Acetaminophen | 14 | $258 | $18 |
| Gabapentin | 14 | $119 | $8 |
| Tizanidine | 11 | $97 | $9 |
| Cyclobenzaprine | 13 | $67 | $5 |
2019: 5 drugs
| Morphine Sulfate Er | 13 | $330 | $25 |
| Hydrocodone-Acetaminophen | 17 | $304 | $18 |
| Oxycodone-Acetaminophen | 11 | $208 | $19 |
| Methocarbamol | 11 | $79 | $7 |
| Cyclobenzaprine | 11 | $50 | $5 |
2018: 4 drugs
| Morphine Sulfate Er | 11 | $352 | $32 |
| Hydrocodone-Acetaminophen | 17 | $317 | $19 |
| Methocarbamol | 11 | $75 | $7 |
| Gabapentin | 11 | $73 | $7 |
2017: 4 drugs
| Hydrocodone-Acetaminophen | 26 | $723 | $28 |
| Morphine Sulfate Er | 12 | $428 | $36 |
| Diazepam | 13 | $174 | $13 |
| Methocarbamol | 12 | $83 | $7 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 30 | $1,108 | $37 |
| Morphine Sulfate Er | 11 | $499 | $45 |
2015: 2 drugs
| Hydrocodone-Acetaminophen | 41 | $999 | $24 |
| Morphine Sulfate Er | 11 | $848 | $77 |
Money from drug and device companies
$320 in 2019
A payment is not proof that care is biased.
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $183 | 1 payment
|
| Nevro | Senza Spinal Cord Stimulation System | $127 | 1 payment
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $11 | 1 payment
|
See all 3 published payments
| BioDelivery Sciences International | Meals · 2019-11-25 | Bunavail 2.1 Mg 30-Count Box | $11 |
| Nevro | Meals · 2019-05-23 | Senza Spinal Cord Stimulation System | $127 |
| Scilex Pharmaceuticals | Meals · 2019-02-25 | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $183 |
Professional record
- NPI
- 1922138528
- Licence
- CA A85402California A85402: Current · expires 2027-09-30
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2081S0010X (2081S0010X)
- Mailing address
- 301 Executive Park Blvd, Apt 503, San Francisco, CA, 94134
- NPI first listed
- 2007-03-06
- NPI last updated
- 2017-02-16
This is when the NPI record was last certified, not a medical board exam.